A 61-year-old with unprovoked DVT on apixaban 5 mg bid for 6 months has low bleeding risk. Preferred extended-phase regimen?...

Question

A 61-year-old with unprovoked DVT on apixaban 5 mg bid for 6 months has low bleeding risk. Preferred extended-phase regimen?

Accepted Answer

Reduce to apixaban 2.5 mg bid for extended prevention

Answer

Stop anticoagulation

Answer

Switch to warfarin INR 2-3

Answer

Continue apixaban 5 mg bid indefinitely

Answer

Switch to aspirin

us-abfm MCQ (SBA): Venous Thromboembolism